San Francisco, California (March 7, 2017) – PuraCath Medical has published the result of its recent research on its ultraviolet (UV) light-based peritoneal dialysis catheter connection system in Peritoneal Dialysis International (PDI), the official Journal of the International Society for Peritoneal Dialysis. PDI is a major source of knowledge in the field of peritoneal dialysis and aims to promote the advancement of peritoneal dialysis knowledge through scientific publications and international scientific meetings.
“Publishing the result of our new research on our UV light-based peritoneal dialysis catheter connection system in PDI is a significant accomplishment for PuraCath team since it signifies approval of the data extracted from our newly designed device by the elite scientific society of peritoneal dialysis,” said Julia Rasooly, PuraCath Medical’s CEO. “We believe our approach towards reducing microbial growth through the use of our inexpensive technology will provide patients on peritoneal dialysis a chemical-free, technique-independent method for reducing bacterial and fungal contamination during peritoneal dialysis exchanges.” In vitro testing demonstrated the effectiveness of the UV light-based peritoneal dialysis catheter connection system in achieving a 4-log reduction of several microorganisms which are known to cause peritonitis in patients on peritoneal dialysis therapy. The mean log reduction of these microorganisms was 4.03 for Candida albicans, 4.73 for Staphylococcus aureus, and 5.29 for Escherichia coli. Here is the link to PuraCath’s article in PDI: http://www.pdiconnect.com/content/37/1/109.short
In 2016, PuraCath received 510(k) clearance for its FireFly Peritoneal Dialysis Connector Disinfecting System which gave the company permission to market the FireFly device in the U.S. The device is intended for use by patients on peritoneal dialysis therapy as a method of controlling air and touch contamination while performing peritoneal dialysis exchanges.